<DOC>
	<DOC>NCT02710513</DOC>
	<brief_summary>The purpose of this study is to evaluate the healthy properties of a dietary intervention based on an innovative pasta enriched with prebiotic fibers (barley beta-glucans). The hypothesis is that the gut microbiota and metabolome, the nutritional status, the redox/subclinical inflammation parameters and the markers of cardiovascular risk may improve in healthy subjects.</brief_summary>
	<brief_title>ProAliFun_6.5_Health Effects of a Functional Pasta Enriched With Barley Beta-glucans on Healthy Subjects</brief_title>
	<detailed_description>This clinical trial is a prospective pilot study, lasting 4 months. A target number of 30 healthy individuals meeting inclusion and exclusion criteria, assessed at enrollment, and which have signed the informed consent, will be recruited.</detailed_description>
	<criteria>healthy subjects aged between 30 and 70 years BMI between 18.5 and 24.9 omnivorous diet informed consent signed diabetes type 2 urine protein &gt; 1g/24h antibiotics and probiotics administration by 15 days before the enrollment gastrointestinal, celiac, inflammatory systemic and chronic liver diseases recent diagnosis of cancer corticosteroid or immunosuppressive therapies previous major acute cardiovascular pathologies (heart attack, cerebral ictus) hyperlipidemia consume of alcohol psychiatric diseases</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>beta-glucans</keyword>
	<keyword>gut microbiota</keyword>
	<keyword>p-cresyl sulphate (pCS)</keyword>
	<keyword>indoxyl sulphate (IS)</keyword>
	<keyword>short-chain fatty acid (SCFA)</keyword>
</DOC>